Stocks TelegraphStocks Telegraph
Stock Ideas

ST Premium

For just $1, you can unlock ST Grading’s top-rated stocks that consistently beat the market. Our AI-powered Smart Screener finds winning trades in seconds, helping you uncover hidden opportunities before others do.

Ready to Win Big?

Try Now for Just $1!

MLYS Company Profile and Key Details

NASDAQ : MLYS

Mineralys Therapeutics, Inc.

$10.52
-0.02-0.19%
At Close 4:00 PM
$15.44
4.92+46.77%
After-Market 04:20 PM
69.18
ESG ScoreESG Rating

MLYS Stock Price Chart

Stock Price Today

Mineralys Therapeutics, Inc. (MLYS) stock surged +42.21%, trading at $14.96 on NASDAQ, up from the previous close of $10.52. The stock opened at $14.13, fluctuating between $13.50 and $18.29 in the recent session.

Stock Snapshot

10.52
Prev. Close
14.13
Open
745.54M
Market Cap
49.84M
Number of Shares
13.5
Day Low
18.29
Day High
-4.09
P/E Ratio
49.33%
Free Float in %
-3.66
EPS (TTM)
6.01
Book Value
-2.02
Cash Flow per Share
15.16M
Volume

Stock Price History Chart

DateOpenHighLowCloseVolume
Mar 07, 202510.5710.7710.1910.52340.99K
Mar 06, 20259.8610.829.6910.55319.71K
Mar 05, 202510.0010.339.8010.01189.7K
Mar 04, 20258.8510.008.799.93290.88K
Mar 03, 20259.179.448.698.94301.36K
Feb 28, 202510.0110.089.009.14448.62K
Feb 27, 20259.7710.249.689.96286.43K
Feb 26, 20258.779.888.769.68315.53K
Feb 25, 20259.289.298.248.76996.1K
Feb 24, 20259.549.589.229.25263.51K
Feb 21, 20259.699.859.379.56335.44K
Feb 20, 20259.339.679.149.53300.5K
Feb 19, 20259.389.508.989.32434.24K
Feb 18, 202510.1910.759.509.60583.14K
Feb 14, 202510.0110.6410.0110.24245.93K
Feb 13, 202510.1510.6710.1510.20373.67K
Feb 12, 202510.6111.099.6510.63395.36K
Feb 11, 20259.349.709.029.66310.14K
Feb 10, 20259.8110.189.449.51233.91K
Feb 07, 202510.0210.859.729.81338.33K

Contact Details

Radnor, PA 19087

United States

Website: https://mineralystx.comContact: 888 378 6240

About Company

Mineralys Therapeutics, Inc., a clinical-stage biopharmaceutical company that develops therapies for the treatment of hypertension and associated cardiovascular diseases. It clinical-stage product candidate is lorundrostat, a proprietary, orally administered, highly selective aldosterone synthase inhibitor for the treatment of patients with uncontrolled or resistant hypertension. The company was incorporated in 2019 and is headquartered in Radnor, Pennsylvania.

Company Information

Employees51
Beta1.51
Sales or Revenue$0.00
5Y Sales Change%0%
Fiscal Year EndsDecember
SectorHealthcare
IndustryBiotechnology

Frequently Asked Questions

What is the current Mineralys Therapeutics, Inc. (MLYS) stock price?
Mineralys Therapeutics, Inc. (NASDAQ: MLYS) stock price is $14.96 in the last trading session. During the trading session, MLYS stock reached the peak price of $18.29 while $13.50 was the lowest point it dropped to. The percentage change in MLYS stock occurred in the recent session was 42.21% while the dollar amount for the price change in MLYS stock was $4.44.
MLYS's industry and sector of operation?
The NASDAQ listed MLYS is part of Biotechnology industry that operates in the broader Healthcare sector. Mineralys Therapeutics, Inc. designs, manufactures, and markets smartphones, personal computers, tablets, wearables, and accessories worldwide.
Who are the executives of MLYS?
Mr. Jeffrey N. Fellows
Senior Vice President of Regulatory Affairs
Ms. Jessica Ibbitson
Senior Vice President of Clinical Operations
Dr. Robert McKean Ph.D.
Senior Vice President of CMC
Ms. Danielle Bradbury
Senior Vice President of Quality Assurance
Mr. Jose Breton CPA
Vice President of Fin. & Controller
Mr. Jon Congleton
Chief Executive Officer & Director
Ms. Cindy Berejikian
Executive Vice President of Operations
Mr. Adam Scott Levy
Chief Financial Officer, Chief Bus. Officer & Sec.
Dr. David Rodman M.D.
Chief Medical Officer
Dr. Brian Taylor Slingsby M.D., M.P.H., Ph.D.
Founder & Executive Chairman
How MLYS did perform over past 52-week?
MLYS's closing price is 27.65% higher than its 52-week low of $8.24 where as its distance from 52-week high of $18.29 is -31.02%.
How many employees does MLYS have?
Number of MLYS employees currently stands at 51.
Link for MLYS official website?
Official Website of MLYS is: https://mineralystx.com
How do I contact MLYS?
MLYS could be contacted at phone 888 378 6240 and can also be accessed through its website. MLYS operates from 150 N. Radnor Chester Rd., Radnor, PA 19087, United States.
How many shares of MLYS are traded daily?
MLYS stock volume for the day was 15.16M shares. The average number of MLYS shares traded daily for last 3 months was 283.16K.
What is the market cap of MLYS currently?
The market value of MLYS currently stands at $745.54M with its latest stock price at $14.96 and 49.84M of its shares outstanding.
logo

Stocks Telegraph provides information and tools designed to assist investors and Wall Street players. A major goal is to offer financiers comprehensive information that will help them gain insight into investing.

Stocks Telegraph does not provide any advice or recommendations for buying or selling stocks, securities, or other financial products. Information contained on this website is for informational purposes only and should not be construed as professional financial, investment or other advice. Stocks Telegraph is not liable for any loss or damage that may occur as a result of reliance on this data.

© 2025 Stocks Telegraph All rights reserved.
Most stock quote data provided by financialmodelingprep.com

stockstelegraph

Don't have an account?

stockstelegraph

Don't have an account?

stockstelegraph

Already have an account?

stockstelegraph
Smart Screening Tools for Exceptional Returns
stockstelegraph

For just $1, you can unlock ST Grading’s top-rated stocks that consistently beat the market. Our AI-powered Smart Screener finds winning trades in seconds, helping you uncover hidden opportunities before others do.

Ready to Win Big?

Try Now for Just $1!
stockstelegraph